Company Unit : Million Baht For the 3 months Change between QoQ Change between YoY For the 9 months Change between YoY Q3/17 Q1/17 Q2/16 Amount % Amount % Q2/17 Q2/16 Amount % Revenues from medical services
pursuant to the actual service usage. The Company expects that demand of the medical services will resume in the second half of the year after insurers have eased their anxiety of the COVID-19 pandemic
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 31st March 2019 as follows. Summary
and the spouse of director. Issuer : Vibhavadi Medical Center Public Company Limited. 3 The general characteristics of the transaction Transaction class : The issuing promissory notes to Specific
-time incurred of approximately Baht 12 million. In addition, the opening of the new Medical Excellence Center and the expansion of the subsidiary’s laboratories have driven the cost of service, expertise
operations incurred compared to total revenues were 65.8% and 68.6% repectively. This increase stemmed from doctor fee, renumeration, and any other fringe benefits, which resulted from the increase of Medical
exceeding 200 MB; totaling to not exceeding 250 MB. In order to expand investment in business concerning healthcare, esthetic, and cosmetic distribution giving importance on Hygienic Medical Service related
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for year ended of 31 December 2017 as follows. The operation results
subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st